LivingGLP1
Study S002658

Acute and Short-term Chronic Effects of Galvus (Vildagliptin) on Endothelial Function and Oxidative Stress on Recently Diagnosed Type 2 Diabetic Obese Women: the Role of Intestinal Peptides During Lipid Overload

Registration

Registration
NCT01827280
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
SINGLE
Status
COMPLETED
Enrollment
40
Start
2013-04
Primary completion
2016-08
Lead sponsor
Rio de Janeiro State University
Conditions
1- Microvascular Function; 2-oxidative Stress; 3-inflammation
Interventions
DRUG:Vildagliptin
Results posted
FALSE
Secondary identifiers
REGISTRY:BioVasc_2013

Registered primary outcomes

  • Change from Baseline in microcirculation function at 30 days [Before and after 30 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.